Showing results (1-10 of 91) with videos related to
Sort By:
Pageof 10
Blood Cancer Discovery|May 6, 2026
Understanding the Molecular Mechanisms Underlying Anemia in Myelodysplastic Syndromes: From Erythropoiesis to New Therapeutic ApproachesVera Adema, Francesco Pesce, Guillermo Garcia-Manero, et al.Cell Reports. Medicine|February 14, 2023
Emerging treatments for myelodysplastic syndromes: Biological rationales and clinical translationJuan Jose Rodriguez-Sevilla, Vera Adema, Guillermo Garcia-Manero, et al.Hematology (Amsterdam, Netherlands)|March 15, 2005
Angiogenic switch in multiple myelomaNicola Giuliani, Simona Colla, Vittorio RizzoliSeminars in Hematology|October 18, 2024
Inflammation in myelodysplastic syndrome pathogenesisJuan Jose Rodriguez-Sevilla, Simona CollaActa Bio-Medica : Atenei Parmensis|March 31, 2005
Update on the pathogenesis of osteolysis in multiple myeloma patientsNicola Giuliani, Simona Colla, Vittorio RizzoliBlood|January 18, 2024
T-cell dysfunctions in myelodysplastic syndromesJuan Jose Rodriguez-Sevilla, Simona CollaExperimental Hematology|August 17, 2004
New insight in the mechanism of osteoclast activation and formation in multiple myeloma: focus on the receptor activator of NF-kappaB ligand (RANKL)Nicola Giuliani, Simona Colla, Vittorio RizzoliDifferentiation; Research in Biological Diversity|January 15, 2018
Dysfunctional telomeres and hematological disordersElena Fiorini, Andrea Santoni, Simona CollaNature Communications|November 13, 2024
The IL-1β inhibitor canakinumab in previously treated lower-risk myelodysplastic syndromes: a phase 2 clinical trialJuan Jose Rodriguez-Sevilla, Vera Adema, Kelly S Chien, et al.Pageof 10